GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GlucoTrack Inc (NAS:GCTK) » Definitions » Shiller PE Ratio

GCTK (GlucoTrack) Shiller PE Ratio : (As of Apr. 12, 2025)


View and export this data going back to 2000. Start your Free Trial

What is GlucoTrack Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


GlucoTrack Shiller PE Ratio Historical Data

The historical data trend for GlucoTrack's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlucoTrack Shiller PE Ratio Chart

GlucoTrack Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GlucoTrack Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GlucoTrack's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, GlucoTrack's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlucoTrack's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GlucoTrack's Shiller PE Ratio falls into.


;
;

GlucoTrack Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GlucoTrack's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, GlucoTrack's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-12.577/133.1571*133.1571
=-12.577

Current CPI (Dec. 2024) = 133.1571.

GlucoTrack Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -403.000 99.621 -538.664
201506 -429.000 100.684 -567.364
201509 -286.000 100.392 -379.344
201512 -390.000 99.792 -520.393
201603 -312.000 100.470 -413.505
201606 -390.000 101.688 -510.692
201609 -390.000 101.861 -509.825
201612 -312.000 101.863 -407.853
201703 -624.001 102.862 -807.781
201706 -624.001 103.349 -803.976
201709 -572.001 104.136 -731.412
201712 -611.001 104.011 -782.216
201803 -442.000 105.290 -558.987
201806 -429.000 106.317 -537.304
201809 -403.000 106.507 -503.840
201812 -4,914.005 105.998 -6,173.091
201903 -13.000 107.251 -16.140
201906 -13.000 108.070 -16.018
201909 -13.000 108.329 -15.979
201912 -13.000 108.420 -15.966
202003 -5.249 108.902 -6.418
202006 -3.999 108.767 -4.896
202009 -3.000 109.815 -3.638
202012 -7.000 109.897 -8.482
202103 -6.000 111.754 -7.149
202106 -6.000 114.631 -6.970
202109 -5.000 115.734 -5.753
202112 -9.000 117.630 -10.188
202203 -7.000 121.301 -7.684
202206 -7.000 125.017 -7.456
202209 -6.000 125.227 -6.380
202212 -9.000 125.222 -9.570
202303 -8.000 127.348 -8.365
202306 -5.400 128.729 -5.586
202309 -9.800 129.860 -10.049
202312 -6.580 129.419 -6.770
202403 -12.000 131.776 -12.126
202406 -16.400 132.554 -16.475
202409 -18.200 133.029 -18.218
202412 -12.577 133.157 -12.577

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GlucoTrack  (NAS:GCTK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


GlucoTrack Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of GlucoTrack's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlucoTrack Business Description

Traded in Other Exchanges
N/A
Address
301 Route 17 North, Suite 800, Rutherford, New Jersey, NJ, USA, 07070
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Executives
Drew Sycoff director C/O ANDREW GARRETT INC, 52 VANDERBILT AVENUE - 20TH FLOOR, NEW YORK NY 10017
James S Cardwell officer: Chief Financial Officer CLINTON SQUARE, 75 S. CLINTON AVE., SUITE 510, ROCHESTER NY 14604
Erin Catherine Carter director 301 RTE 17 NORTH, STE. 800, RUTHERFORD NJ 07070
Allen Danzig director 301 RT 17 NORTH, SUITE 800, RUTHERFORD NJ 07070
Shimon D Rapps director C/O ANDREW GARRETT, INC., 52 VANDERBILT AVENUE SUITE 510, NEW YORK NY 10017
David Podwalski officer: Chief Commercial Officer 19 HA'YAHALOMIM ST., P.O. BOX 12163, ASHDOD L3 7760049
Michael Hauck director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
John A Graham director, officer: Chief Executive Officer 19 HA'YAHALOMIM STREET, P.O. BOX 12163, ASHDOD L3 7760049
Sami Sassoun officer: Chief Financial Officer 39-06 ACKERMAN DRIVE, FAIR LAWN L3 7760049
Philip Darivoff director 1 FARMSTEAD ROAD, SHORT HILLS NJ 07078
Revan Schwartz director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
Leslie Seff director PO BOX 59, 40 HELLBROOK LANE, ULSTER PARK NY 12487
Angela Strand Boydston director C/O AEROGEN, INC., 2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043
Eran Hertz officer: Chief Financial Officer C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L3 78100
Israel B. Ehrlich director C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L378100